Page last updated: 2024-09-05

sorafenib and Barrett Esophagus

sorafenib has been researched along with Barrett Esophagus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bissonnette, M; Chumsangsri, A; Cohen, EE; Delgado, J; Keswani, RN; Mustafi, R	1

Other Studies

1 other study(ies) available for sorafenib and Barrett Esophagus

Article	Year
Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2008, Volume: 21, Issue:6 Topics: Adenocarcinoma; Analysis of Variance; Barrett Esophagus; Benzenesulfonates; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Humans; Mitogen-Activated Protein Kinases; Niacinamide; Phenylurea Compounds; Probability; Protein Kinase Inhibitors; Pyridines; Reference Values; Sorafenib	2008

Article

Year

Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2008, Volume: 21, Issue:6

Topics: Adenocarcinoma; Analysis of Variance; Barrett Esophagus; Benzenesulfonates; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Humans; Mitogen-Activated Protein Kinases; Niacinamide; Phenylurea Compounds; Probability; Protein Kinase Inhibitors; Pyridines; Reference Values; Sorafenib

2008